期刊文献+

正常宫颈和宫颈鳞癌组织中的微血管的定量研究 被引量:2

Microvessel Count in Normal Cervical Tissue and in Cervical Carcinomas
暂未订购
导出
摘要 为探讨微血管在正常宫颈组织和宫颈鳞癌中的状况,采用免疫组化LSAB法对80例宫颈鳞癌和15例正常宫颈组织中的微血管数进行了检测。结果显示:①正常宫颈组织中微血管数明显低于宫颈鳞癌;②微血管数与宫颈鳞癌临床分期呈正相关(在200倍显微镜视野下:Ⅰb期为14.51±6.51根,Ⅱ期为19.84±4.73根,Ⅲ期为32.26±6.82根),与外生型肿瘤的菜花直径大小有关(在200倍显微镜视野下:直径≤4cm,MVC=18.08±7.56根;直径>4cm,MVC=23.91±8.05根),与淋巴结转移状况有关(LPG+,MVC=24.13±9.83根;LPG-,MVC=18.54±5.99根),均P<0.05,且在200倍显微镜下每增加5根血管,肿瘤发生淋巴结转移的机会将增加1.61倍,而与组织学分级无关。结果提示:微血管计数能够反映宫颈癌的恶性潜能,是观察宫颈癌预后的重要指标。 This study was conducted to determine microvessel count(MVC) status in normal cervical tissue (NCT) and in cervical carcinomas(CCs). 15 cases of NCT and 80 cases of CCs were stained by immunohistochemical method for Factor related antigen (F8RA). The results showed that the MVC in CCs was much higher than that in NCT and it was correlated with clinical stage, size of tumor and lymph node status (P<0.05). Every time when MVC increased by 5 in number (LM200, field 0.739 mm2), the chance of lymph node metastasis increased by 1.61 times. There was no relationship between MVC and tumor grade. These suggested that MVC might be a useful early parameter in the diagnosis and prognosis of CCs.
出处 《华西医科大学学报》 CSCD 1999年第2期176-178,183,共4页 Journal of West China University of Medical Sciences
关键词 微血管数 子宫颈鳞癌 预后指标 子宫颈 Microvessel count cervicalCarcinomasPrognosis parameter
  • 相关文献

同被引文献26

  • 1Smith K M,Cancer Res,1997年,57卷,3期,1294页
  • 2Tjiong MY,Out TA,Ter SJ,et al.Epidemiologic and mucosal immunologic aspects of HPV infection and HPV-related cervical neoplasia in the lower female genital tract:a review[J].Int J Gynecol Cancer,2001,11(1):9-17.
  • 3Van Beurden M,Ten Kate FW,Tjion-A-Hung SP,et al.Human paplillomavirus DNA in multicentric vulvar intraepithelial neoplasia[J].Int J Gynecol Pathol,1998,17(1):12-16.
  • 4Konno R,Paez C,Sato S,et al.HPV,histological grade and age-risk factors for theprogression of cervical intraepithelial neoplasia[J].J Reprod Med,1998,43(7):561-566.
  • 5Queimado L,Lope C,Du F,et al.In vitro transformation of cell lines from human salivary gland tumors[J].Int J Cancer,1999,81(5):793-798.
  • 6Kato H,Toriger T.Radioimmunoassay for tumor antigen of human cervical squamous cell carcinoma[J].Cancer,1977,40(3):1621-1628.
  • 7Suminami Y,Nagashima S,Vujanovic NL,et al.Inhibition of apoptosis in human tumorcellby the tumor-associated serpin,SCC antigen-1[J].Brit J Cancer,2000,82(4):981-989.
  • 8Lin H,Chang Chien CC,Huang EY,et al.The role of radical surgery followed by adjuvant therapy for high-risk early-stage cervical carcinoma patients with pelvis lymph node metastasis[J].Eur J Obstet Gynecol Reprod Biol, 2000,93(1):85-90.
  • 9Lin H, Chang Chien CC, Huang EY, et al. The role of pretreatment squamous cell carcinoma antigen in predicting nodal metastasis in early cervical cancer[J].Acta Obstet Gynecol Stand, 2000,79(2):140-144.
  • 10Strauss HG, Laban C, Lautenschlager C, et al. SCC antigen in the serum as an independent prognostic factor in operable squamous cell carcinoma of the cervix[J].Eur J Cancer, 2002,38(15):1987-1991.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部